Arkolith/Insider Trading/PMVP/Form 4

Mack David Henry

President and CEO, DirectorPMV Pharmaceuticals, Inc. (PMVP) · full profile →Form 4 · filed Apr 29, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2022Option exercise(M)33K$0.53$17K80K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2022Option exercise(M)33K—$0393K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-026341) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML